Evidence map›Paper›PMID 19726787›Full record

ArticleJournal of biomolecular screening2009

Live-cell imaging of caspase activation for high-content screening.

Christophe Antczak, Toshimitsu Takagi, Christina N Ramirez, Constantin Radu, Hakim Djaballah

Open access · bronzeAbstract readValidation Study
In one paragraph

Article in Journal of biomolecular screening, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. A high content assay to assess cellular fitness.Combinatorial chemistry & high throughput screening · 2014
    Article
  12. Remedial applications of silencing ribonucleic acids and modalities for its delivery to the kidneys--a review.African journal of traditional, complementary, and alternative medicines : AJTCAM · 2014
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. High-content assay to identify inhibitors of dengue virus infection.Assay and drug development technologies · 2010
    Article
  19. Cytometry in cell necrobiology revisited. Recent advances and new vistas.Cytometry. Part A : the journal of the International Society for Analytical Cytology · 2010
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Christophe AntczakHigh Throughput Screening Core Facility, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
Toshimitsu Takagi
Christina N Ramirez
Constantin Radu
Hakim Djaballah
Memorial Sloan Kettering Cancer Center · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Novel & Selective Small Molecular Inhibitors of Human Peptide DeformylaseR21NS057008 · NINDS · SLOAN-KETTERING INST CAN RESEARCH · PI DJABALLAH, HAKIM · 2006 to 2006
$220k
NCI NIH HHS 5 P30 CA008748-44NCI NIH HHS P30 CA008748NINDS NIH HHS R21 NS057008
6 · The paper itself

Abstract

Caspases are central to the execution of programmed cell death, and their activation constitutes the biochemical hallmark of apoptosis. In this article, the authors report the successful adaptation of a high-content assay method using the DEVDNucView488 fluorogenic substrate, and for the first time, they show caspase activation in live cells induced by either drugs or siRNA. The fluorogenic substrate was found to be nontoxic over an exposure period of several days, during which the authors demonstrate automated imaging and quantification of caspase activation of the same cell population as a function of time. Overexpression of the antiapoptotic protein Bcl-XL, alone or in combination with the inhibitor Z-VAD-FMK, attenuated caspase activation in HeLa cells exposed to doxorubicin, etoposide, or cell death siRNA. This method was further validated against 2 well-characterized NSCLC cell lines reported to be sensitive (H3255) or refractory (H2030) to erlotinib, where the authors show a differential time-dependent activation was observed for H3255 and no significant changes in H2030, consistent with their respective chemosensitivity profile. In summary, the results demonstrate the feasibility of using this newly adapted and validated high-content assay to screen chemical or RNAi libraries for the identification of previously uncovered enhancers and suppressors of the apoptotic machinery in live cells.

Indexed as

Amino Acid Chloromethyl KetonesAntineoplastic AgentsApoptosisbcl-X ProteinCaspase InhibitorsCaspasesCell Line, TumorCell SurvivalCysteine Proteinase InhibitorsDiagnostic ImagingDrug Screening Assays, AntitumorEnzyme ActivationHeLa CellsHigh-Throughput Screening AssaysHumansModels, BiologicalAmino Acid Chloromethyl KetonesAntineoplastic AgentsBCL2L1 protein, humanbcl-X Proteinbenzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketoneCaspase InhibitorsCaspasesCysteine Proteinase Inhibitors

Identifiers

PMID19726787
PMCPMC3613133
OpenAlexW1965555958

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.